Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Revolution Medicines, Inc.
Janssen Research & Development, LLC
Varian, a Siemens Healthineers Company
Cogent Biosciences, Inc.
Verastem, Inc.
Boehringer Ingelheim
Bayer
Merck Sharp & Dohme LLC
Replimune Inc.
AstraZeneca
Intima Bioscience, Inc.
Carevive Systems, Inc.
Pilatus Biosciences Inc
Amgen
GlaxoSmithKline
Pfizer
DualityBio Inc.
SOFIE
Lumicell, Inc.
RemeGen Co., Ltd.
Freenome Holdings Inc.
Anthos Therapeutics, Inc.
Hoffmann-La Roche
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
Shanghai Juncell Therapeutics
Société des Produits Nestlé (SPN)
DualityBio Inc.
GlaxoSmithKline
BicycleTx Limited
IDRx Inc. - A GSK Company
Elevation Oncology
Revolution Medicines, Inc.
BioMed Valley Discoveries, Inc
Bolt Biotherapeutics, Inc.
Jazz Pharmaceuticals
Arbele Limited
Revolution Medicines, Inc.
RefleXion Medical
Pfizer
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Tempus AI
Imugene Limited
Revolution Medicines, Inc.
Boehringer Ingelheim
Erasca, Inc.
Mirai Medical